| 发明名称 | Probiotics, secretory IgA and infection | ||
| 摘要 | Ways to increase the effectiveness of probiotics is disclosed. One embodiment relates to a combination of probiotics with secretory IgA and possible uses of this combination. For example, a method of using a composition comprising secretory IgA and at least one probiotic to prepare a product to treat or prevent infection is disclosed. | ||
| 申请公布号 | US9629908(B2) | 申请公布日期 | 2017.04.25 |
| 申请号 | US201514872326 | 申请日期 | 2015.10.01 |
| 申请人 | Nestec S.A. | 发明人 | Benyacoub Jalil;Corthesy Blaise;Blum-Sperisen Stephanie;Favre Laurent |
| 分类号 | A61K39/00;A61K39/235;A01N63/00;A01N65/00;A61K39/395;A61K35/744;A61K35/745;A61K35/747;A61K35/741;A23L33/00;A23L33/135 | 主分类号 | A61K39/00 |
| 代理机构 | K&L Gates LLP | 代理人 | K&L Gates LLP |
| 主权项 | 1. A product comprising SIgA and a probiotic micro-organism and selected from the group consisting of a food product formulated for consumption by humans, an animal food product, and a pharmaceutical composition, the SIgA and the probiotic micro-organism are present in the form of a complex with each other, and the SIgA and the probiotic micro-organism are present in the product in a stoichiometric ratio of at least 100:1. | ||
| 地址 | Vevey CH | ||